Scholarlink

<p>In a recent study to evaluate the presence of more than one hundred Emerging Substances of Concern (ESoCs) in drinking water and treated municipal wastewater, we detected several pharmaceuticals that have not been reported as widely in the literature as other pharmaceuticals. The objective of the present technical note was to highlight the present of some compounds to stimulate interest for including them more systematically in monitoring programs and research. These six ESoCs that were detected in treated wastewater at concentrations &gt; 100 ng/L and in some cases, also detected in drinking water include two antimicrobials (clarithromycin, azithromycin), two anti-convulsants (lamotrigine, topiramate) and two medications used to treat high blood pressure (hydrochlorothiazide, irbesartan).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Emerging Substances of Concern (ESoCs) to Consider as Priorities for Monitoring in Drinking Water and Municipal Wastewater

  • 期刊论文

  • 发表日期：

    2026年3月28日

查看全文
  • Viviane Yargeau,
  • Chris D. Metcalfe

摘要

In a recent study to evaluate the presence of more than one hundred Emerging Substances of Concern (ESoCs) in drinking water and treated municipal wastewater, we detected several pharmaceuticals that have not been reported as widely in the literature as other pharmaceuticals. The objective of the present technical note was to highlight the present of some compounds to stimulate interest for including them more systematically in monitoring programs and research. These six ESoCs that were detected in treated wastewater at concentrations > 100 ng/L and in some cases, also detected in drinking water include two antimicrobials (clarithromycin, azithromycin), two anti-convulsants (lamotrigine, topiramate) and two medications used to treat high blood pressure (hydrochlorothiazide, irbesartan).